No Data
Japanese stock buybacks this week (3/3~3/7)
――――3/3――――$Amiya(4258.JP)$ will buy back up to 100K shares, 2.42% of its outstanding shares (excluding its own shares), for an amount of JPY¥ 300 million.$Mizuho Financial Group(8411.JP)$ will
List of conversion stocks (part 3) [Parabolic Cigna Corp conversion stocks list]
○ List of stocks converting to Sell in the market Code Stock Name Closing Price SAR Main Board <6986> Futaba Electric 516 546 <7130> Yamae Group HD 21932287 <7187> J Lease 13171385 <7202> Isuzu 19882065 <7224> ShinMaywa Industries 13571418 <7245> Daido Metal 498513 <7269> Suzuki 18802014 <729
Yellow Hat Ltd. Announces Stock Split and Shareholder Benefit Changes
February 3rd [Today's Investment Strategy]
[Fisco Selected Stock] 【Material Stock】 Meiden Corporation <6508> 4000 yen (January 31) Engaged in four areas: electrical utilities infrastructure, social systems, industrial electronic mobility, and field engineering. Revised upward the financial estimates for the fiscal year ending March 2025. Operating profit is estimated to be 18.5 billion yen (a 45.3% increase compared to the previous term). This is about a 15% increase from the previous estimates. Although there is a decline in demand for the EV business, there is robust demand, particularly in the electrical utilities infrastructure and field engineering businesses.
Focus on Lasertech and Sumitomo Pharma, while Ample and SMS seem sluggish.
Last weekend, on January 31, in the U.S. stock market, the Dow Jones Industrial Average fell by $337.47 to 44,544.66, the Nasdaq Composite Index decreased by 54.31 points to 19,627.44, and the Chicago Nikkei 225 Futures dropped by 275 yen compared to the Osaka day session, closing at 39,355 yen. The exchange rate is 1 dollar = 154.80-90 yen. In today's Tokyo market, Lasertech <6920> saw its operating profit for the first half rise to 2.0 times that of the same period last year, and Kameda Seika <2220> reported an increase of 48.8% in operating profit for the cumulative third quarter.
＜Today's individual materials＞ Yellow Hat, J-Power, Japan Pharmaceutical, JCR Pharma, ETC (Announced on January 31st)
▽ Yellow Hat <9882.T> - As of March 31, a stock split from one share into two will take effect on April 1. ▽ J-Power <9513.T> has upwardly revised its consolidated financial estimates for the fiscal year ending March 25. ▽ Japan Medical <3341.T> has lowered its consolidated net profit estimates for the fiscal year ending March 25. ▽ JCR Pharma <4552.T> has downwardly revised its consolidated financial estimates for the fiscal year ending March 25. ▽ Kinden <1944.T> has upwardly revised its consolidated financial estimates and dividends for the fiscal year ending March 25, and also announced the acquisition and cancellation of its own shares. ▽ Fuji